NM17-02

Main Content

Evaluation of the impact of changing clinical profile, transplant conditioning regimens and stem cell source on clinical outcome in patients with thalassemia major.

Study #: NM17-02

Study Status: Published

Presentation(s)

2018, ASH (Oral)

Related and unrelated donor transplantation for β-thalassemia major: Results of an international survey.

Citation

Li C, Mathews V, Kim S, George B, Hebert K, Jiang H, Li C, Zhu Y, Keesler DA, Boelens JJ, Dvorak CC, Agarwal R, Auletta JJ, Goyal RK, Hanna R, Kasow K, Shenoy S, Smith AR, Walters MC, Eapen M.

Blood Advances. 2019, Sep 10: 3(17): 3(17):2562-2570. doi: 10.1182/bloodadvances.2019000291. Epub 2019, Aug 30. PMCID:PMC6737407.

PubMed

PMID: 31471325

Abstract